Association between use of sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 agonists, and dipeptidyl peptidase 4 inhibitors with kidney outcomes in patients with type 2 diabetes: A systematic review and network meta-analysis

BACKGROUND: This study aimed to compare the efficacies of sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like peptide 1 (GLP-1) agonists, and dipeptidyl peptidase 4 (DPP-4) inhibitors on kidney outcomes in patients with type 2 diabetes using network meta-analysis. METHODS: PubMed, EMBA...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuo, He, Wei, Zhao, Lu, Mi, Yaochuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009659/
https://www.ncbi.nlm.nih.gov/pubmed/35421174
http://dx.doi.org/10.1371/journal.pone.0267025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009659/
https://www.ncbi.nlm.nih.gov/pubmed/35421174
http://dx.doi.org/10.1371/journal.pone.0267025

Ejemplares similares